Michael Pantze

Cholestatic Potential of Troglitazone as a Possible Factor Contributing to Troglitazone-Induced Hepatotoxicity: In Vivo and in Vitro Interaction at the Canalicular Bile Salt Export Pump (Bsep) in the Rat

Christoph Funk, Christiane Ponelle, Gerd Scheuermann et al. · Molecular Pharmacology · 2001 · 290 citations

METABOLISM AND EXCRETION OF ERLOTINIB, A SMALL MOLECULE INHIBITOR OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE, IN HEALTHY MALE VOLUNTEERS

Jie Ling, Kim A. Johnson, Zhuang Miao et al. · Drug Metabolism and Disposition · 2005 · 219 citations

Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration

Yanan Zheng, Devin B. Tesar, Lisa J. Benincosa et al. · mAbs · 2012 · 135 citations · Full text

Immunocytochemical Technique, Immunology, Pharmacotherapy +17

The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP™) predicts in vivo metabolic inhibition

Ashok Rakhit, Michael Pantze, Scott Fettner et al. · European Journal of Clinical Pharmacology · 2007 · 120 citations

Pharmacokinetic Modeling, Cyp3a4 Inhibition, Erlotinib Pharmacokinetics +8

Anti-Inflammatory Properties of Docosahexaenoic and Eicosapentaenoic Acids in Phorbol-Ester-lnduced Mouse Ear Inflammation

Daniel Raederstorff, Michael Pantze, Heinrich Bachmann et al. · International Archives of Allergy and Immunology · 1996 · 39 citations

Inflammation, Anti-inflammatory, Allergy +12